14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 ABEO stock ended at $4.40. This is 3.51% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.82% from a day low at $4.33 to a day high of $4.62.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Abeona Therapeutics Inc. prices

Date Open High Low Close Volume
May 01, 2013 $0.490 $0.490 $0.440 $0.480 35 000
Apr 30, 2013 $0.420 $0.500 $0.420 $0.500 50 000
Apr 29, 2013 $0.380 $0.420 $0.370 $0.420 90 000
Apr 26, 2013 $0.370 $0.400 $0.360 $0.380 35 000
Apr 25, 2013 $0.360 $0.390 $0.360 $0.390 10 000
Apr 24, 2013 $0.370 $0.390 $0.370 $0.390 10 000
Apr 23, 2013 $0.400 $0.400 $0.360 $0.390 25 000
Apr 22, 2013 $0.400 $0.400 $0.360 $0.390 105 000
Apr 19, 2013 $0.410 $0.410 $0.400 $0.400 35 000
Apr 18, 2013 $0.430 $0.430 $0.420 $0.430 65 000
Apr 17, 2013 $0.440 $0.440 $0.410 $0.440 5 000
Apr 16, 2013 $0.410 $0.440 $0.410 $0.440 0
Apr 15, 2013 $0.410 $0.440 $0.410 $0.440 30 000
Apr 12, 2013 $0.420 $0.450 $0.420 $0.450 30 000
Apr 11, 2013 $0.430 $0.450 $0.420 $0.450 60 000
Apr 10, 2013 $0.430 $0.460 $0.430 $0.460 5 000
Apr 09, 2013 $0.450 $0.460 $0.430 $0.460 50 000
Apr 08, 2013 $0.490 $0.500 $0.440 $0.480 15 000
Apr 05, 2013 $0.490 $0.500 $0.490 $0.500 15 000
Apr 04, 2013 $0.510 $0.550 $0.480 $0.510 15 000
Apr 03, 2013 $0.440 $0.510 $0.430 $0.510 20 000
Apr 02, 2013 $0.450 $0.510 $0.430 $0.440 45 000
Apr 01, 2013 $0.490 $0.510 $0.480 $0.510 10 000
Mar 28, 2013 $0.420 $0.490 $0.410 $0.490 125 000
Mar 27, 2013 $0.430 $0.450 $0.420 $0.440 15 000
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT